INBIOGEN Co., Ltd. (KRX:101140)
South Korea · Delayed Price · Currency is KRW 5,030.00
-320.00 (-5.98%)
At close: Aug 3, 2026
INBIOGEN Market Cap
INBIOGEN has a market cap or net worth of 50.22 billion as of August 3, 2026. Its market cap has decreased by -44.85% in one year.
Market Cap
50.22B
Enterprise Value
50.80B
Revenue
5.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,030.00
ChartMarket Cap Chart
Since August 14, 2008, INBIOGEN's market cap has decreased from 218.39B to 50.22B, a decrease of -77.00%. That is a compound annual growth rate of -7.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 50.22B | -52.05% |
| Dec 30, 2025 | 104.74B | 103.00% |
| Dec 29, 2022 | 51.60B | -72.31% |
| Dec 30, 2021 | 186.34B | -26.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JS Corporation | 352.55B |
| Au Brandz Co.,Ltd | 265.09B |
| BAIKSAN Co,. | 196.33B |
| Hwaseung Enterprise | 184.80B |
| SYTS Corp. | 146.52B |
| HWASEUNG Industries | 116.68B |
| Nine & Company | 98.43B |
| Uni-Chem | 29.66B |